![](/img/cover-not-exists.png)
996PCETUXIMAB RELATIVE DOSE INTENSITY (RDI) IN RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN): FIRST OBSERVATIONAL PROSPECTIVE STUDY IN UNSELECTED PATIENTS (DIRECT TRIAL)
Guigay, J., Peyrade, F., Petre-Lazar, B., Mornex, F., Ceruse, P., Digue, L., Berrier, A., Degardin, M., Alfonsi, M., Artignan, X., Cals, L., Faivre, S., Vuillemin, E., Rolland, F., Timochenko, A., BabVolume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu340.11
Date:
September, 2014
File:
PDF, 64 KB
2014